Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Invitae | RCV001032803 | SCV001196110 | pathogenic | not provided | 2020-01-03 | criteria provided, single submitter | clinical testing | This variant is an in-frame deletion of the genomic region encompassing exons 63-64 of the USH2A gene. It preserves the integrity of the reading frame. Deletions of exons 63-64 have been observed in individuals affected with clinical features of retinitis pigmentosa and/or hearing loss (PMID: 28041643, 26969326, Invitae). This variant disrupts the p.Thr4439 amino acid residue in USH2A. Other variant(s) that disrupt this residue have been determined to be pathogenic (PMID: 25521520, 22135276, 27460420). This suggests that this residue is clinically significant, and that variants that disrupt this residue are likely to be disease-causing. For these reasons, this variant has been classified as Pathogenic. |